Product Image

Ginkgo Leaf 2000 mg Alcohol-Free

Nature's Answer
4.8
★ ★ ★ ★ ★
(4566 ratings)
Ginkgo
Product Image
Score68
Flexible liquid dosing cannot compensate for an unusually large, poorly defined ginkgo amount and missing purity standards.
How scoring works
Quantity:1 Fluid Ounce(s) • (15 servings)
Goals:
Mental Focus
Brain Health
Productivity Boost

Score 68

Flexible liquid dosing cannot compensate for an unusually large, poorly defined ginkgo amount and missing purity standards.
How scoring works
$12.74($0.84 per serving)
iHerb
$ 12.74
Pure Formulas
$ 12.74
Amazon
$ 12.74
Vitacost
$ 12.74
Report prices

Analysis

A liquid format can help users adjust the serving and avoid capsules. The 2,000 mg label claim appears substantial, but the supplied data does not say whether it is actual extract weight or an herbal-equivalent figure.

Flavonglycoside and terpene-lactone percentages, an extract ratio, and a ginkgolic-acid limit are all missing. Without them, the amount cannot be mapped reliably to the standardized ginkgo preparations used for cognitive outcomes.

The small bottle provides only 15 listed servings and is a poor choice for anyone who wants a clearly characterized daily dose. Medication interactions and surgery timing deserve particular attention because both active exposure and purity remain uncertain.

Who is it for
  • Adults who need an alcohol-free liquid and can verify the extract-equivalent labeling
  • People unable to swallow capsules
Best for
  • Flexible liquid administration
  • Short-term use after confirming the dose interpretation

Pros

  • Uses an alcohol-free liquid format
  • Allows flexible serving adjustment
  • Lists the ginkgo amount
  • Suitable for users avoiding capsules

Cons

  • The 2,000 mg amount is difficult to interpret
  • No extract ratio is provided
  • Active-marker percentages and purity limits are absent
  • Only 15 servings are listed

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.
  • Confirm whether 2,000 mg is an herbal equivalent or actual extract before use because the distinction materially changes dose interpretation.

Nutrient quality

70 High impact

The alcohol-free liquid offers convenient, focused ginkgo delivery. Missing extract ratio, marker percentages, and purity limits make the large stated amount difficult to interpret.

.

Ingredient transparency

74 High impact

All listed active amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.

.

Customer satisfaction

72 High impact

The supplied average rating is strong and comes from a large rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

54 Moderate impact

The single-active formula is focused, but the serving cost is relatively high. Unclear extract equivalence and absent standardization weaken practical value.

.
Report analysis

Goals

Mental Focus
Impact
Moderate effect
C+ Goal FitD Strength of SupportD- CoverageA Formula Quality

Ginkgo may support attention through cerebral circulation, but its benefit is usually modest and depends on extract quality. Flexible liquid dosing is convenient, yet the very large listed amount may be an herbal equivalent rather than a directly comparable extract dose.

Missing active-marker percentages and ginkgolic-acid limits prevent a confident potency and purity assessment. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies
Brain Health
Impact
Moderate effect
B- Goal FitF Strength of SupportF CoverageA Formula Quality

Ginkgo may support cerebral circulation and selected cognitive outcomes, particularly in older adults. Benefits are less consistent in young, healthy users.

The very large listed amount lacks flavone-glycoside, terpene-lactone, and ginkgolic-acid specifications, so potency and safety cannot be verified. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, and the uncertain high amount makes that concern more important.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
Moderate effect
C- Goal FitF Strength of SupportF CoverageB+ Formula Quality

Ginkgo may support mental clarity through cerebral circulation. The evidence cannot be applied confidently because the extract lacks standardization details.

The listed amount is far above the usual supported range if it represents actual extract rather than herbal equivalent. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba Leaf Extract
2000 mg
Gluten Free Adults 18–50 Kosher Dairy Free Women Vegetarian
Report overview
Ginkgo · 2000 mg OverallScore23
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The liquid format allows flexible dosing, but the extract lacks active-marker and ginkgolic acid specifications. The listed amount is far above the supported daily range and may raise side-effect concerns if it represents the actual dose rather than an herbal equivalent. The high serving cost does not offer verifiable value without standardization.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  2. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  3. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  4. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  5. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  6. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  7. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  8. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  9. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  10. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  11. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  12. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  13. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  14. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  15. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  16. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  17. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsProductivity Boost forGinkgo
  18. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo